A NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF NILOTINIB IN BULK AND PHARMACEUTICAL FORMULATIONS
J. Maheshwari*, Allakonda Rajamani Dr. A. Yasodha and Jabeen
ABSTRACT
A simple, rapid, specific and accurate reverse phase high performance liquid chromatographic method has been developed for the validated of Nilotinib in bulk as well as in marketed pharmaceutical dosage form. This separation was performed on a Symmetry ODS C18 (4.6×250mm, 5μm) column with Methanol: Phosphate Buffer (35:65) v/v as mobile phase at a flow rate of 1.0 mL min−1 with UV detection at 235 nm; the constant column temperature was Ambient. The run time under these chromatographic conditions was less than 8 min. The retention time of Nilotinib was found to be 2.276min. The calibration plot was linear over the concentration range of 6–14 μg mL−1 with limits of detection and quantification values of 1.2 and 3.6 ng mL−1 respectively. The mean % assay of marketed formulation was found to be 99.86%, and % recovery was observed in the range of 98-102%. Relative standard deviation for the precision study was found <2%.The developed method is simple, precise, specific, accurate and rapid, making it suitable for estimation of Nilotinib in bulk and marketed pharmaceutical dosage form dosage form.
Keywords: Nilotinib, RP-HPLC, Validation, Precision, ICH Guidelines.
[Full Text Article]
[Download Certificate]